Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Innovaderma Plc LSE:IDP London Ordinary Share GB00BT9PTW34 ORD EUR0.10
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 40.00 39.00 41.00 40.00 40.00 40.00 41,847 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 10.1 1.1 5.5 7.9 7

Innovaderma Share Discussion Threads

Showing 23501 to 23524 of 23825 messages
Chat Pages: Latest  941  940  939  938  937  936  935  934  933  932  931  930  Older
DateSubjectAuthorDiscuss
09/7/2020
16:57
don't forget we had the trading update in late May this year which stated "the Board expects the Group's revenue for FY2020 to be no less than the prior year (£12.9m.). As in the prior year, the second half is expected to be both profitable and cash generative." We did not have a similar update last year so the company was obliged to issue a year end trading update - early July last year, late June in previous 2 years. So technically if nothing has significantly changed then no further update is required. No news is not bad news. However, IMHO maybe company will issue an update in next few trading days and perhaps the delay is to enable other announcements to be added e.g. additional nuthing agreements or even a US retail deal for ST. Who knows.
shandypants2
09/7/2020
16:46
A lot of companies are delaying TUs & results slightly. So personally I wouldn't read anything into it. Audits are bound to drag on when conducted remotely.
lord loads of lolly
09/7/2020
16:07
I'm cynical but if the results were positive they would have got them out by now. Given the history of results announcements with this company I expect some bombshell to happen the same day.
muzmanoz
08/7/2020
18:05
Its got to be sometime this week based on previous years. I've not heard of a delay but its been a crazy year
57eady eddie
08/7/2020
13:59
Anyone know what date the update will be?
vwjs123
04/7/2020
21:37
Good point. I missed this. Notice it was 2nd July last year - which was a really positive update but HC sold into it causing the share price to fall. Really frustrating, but we can have confidence this these sort of tricks aren't going to happen again. Why do you say it seems to be selling well in Tesco? Is is what you've been seeing in your local store?
57eady eddie
04/7/2020
20:36
Skinny tan seems to be selling well in Tesco should get update shortly for half year.
doc robinson
02/7/2020
11:02
Some interesting info here about Mark Ward: hTTps://uk.linkedin.com/in/mmward1 Looks like he came into money when his company (Hunter Macdonald Ltd) joined forces with Netcompany, which led to an IPO. He left a year later "to focus on investing in fast growing, customer centric organisations."
lord loads of lolly
02/7/2020
07:38
Seems to be keen to build a stake?
doc robinson
01/7/2020
10:12
Mark Ward over the million now......tick tock 7.68%
coldspring
24/6/2020
11:19
Final push before year end at skinnytan.co.uk Loads of deals this week - 4 for forty quid and a £10 offer each day. Also loads of bundles inc 2 for 1 on new Coconut water tanner. Use SHIPFREE at checkout to save on P&P Fill your boots , or your wife's/girlfriends/mates/daughters etc
shandypants2
23/6/2020
15:43
Have zero shares been traded today? Looks odd...
bobbyaxlerod
21/6/2020
18:23
Skinny tan well positioned in local Tesco superstore. Just hope it takes off in USA..May get a end of year trading statement in early July if things are going better than expected. Seems very cheap at just over 10 mil capitalisation ?
doc robinson
18/6/2020
14:54
Do we know who is selling down?
bobbyaxlerod
18/6/2020
12:58
Looks like we have a buyer in the background still. I wonder if Mark Ward is accommodating the large sells of the last couple of days.
markiemark321
17/6/2020
17:32
Agreed, a different sector requires a different marketing approach. But revenues of almost £300K in the first full year's trading suggests they're onto something. And if Life Sciences achieves 5% total sales in 2020, that could well be 10% total profit, which ain't to be sneeezed at! Prolong's gross margin is way higher than IDP's other divisions, whilst its marketing costs appear modest. Not trying to contradict you, as you may well be right. Management might not view Life Sciences as core and there's only so much they can focus on. But for me, it's an exciting commercial proposition that could significantly boost profitability, de-risking the over all business. As you say, ST, Roots, Nuthing etc. rely quite heavily on social media and a fashion-driven audience. Longer term, that's potentially a much more fickle market than Prolong's, which is more "needs-driven".
lord loads of lolly
17/6/2020
15:40
Another thing to consider is that it's a completely different sell and route to market. Social media and word of mouth won't really work. So maybe they currently don't have the skill set to make a proper go at life sciences.
boonboon
17/6/2020
14:19
Lord Lolly - Life Sciences, so essentially Prolong, generated £299k rev in 2019 and £102k the year before (albeit 2018 was in only 2 months). Therefore, the 71% H1 increase is from a low base - maybe £100k increased to £170k (as marketing was only restarted in H2 last year). Marketing costs appears to be limited, but targeted, too. Yes it has huge potential but IDP as a small company has thus far only be able to spend limited resources on it and i can't see this changing massively going forward. If it does a minimum of £500k via DTC in 2020 accounts i'll be reasonably pleased - but that's less than 5% of total revenues. As Boon said, happy to be proved wrong
shandypants2
16/6/2020
14:28
I beg to differ. Life Sciences is potentially a HUGE growth area, with far higher selling prices and margins than ST, Roots, Nuthing etc. Serving a different sector, it also diversifies risk nicely. Agreed, though, that they may not have the resource to fully exploit it currently. Doubt they'll ditch this division though. If they did, I'd bail out PDQ.
lord loads of lolly
16/6/2020
13:43
I think you’re right. I wouldn’t be surprised if they sold off life sciences to concentrate on their high growth areas. There must be some value in selling them off, this could be used for addition marketing and distribution deals for ST and Nuthing.
bobbyaxlerod
15/6/2020
15:33
I'd be more than happy to be proved wrong. I just don't think it's the focus right now.They also mentioned a Growlase wet products launch within 6 weeks and that hasn't happened as focus has, rightly imo, turned elsewhere.
boonboon
15/6/2020
14:47
Not sure that's quite the case, though progress does seem to have slowed. Haris was championing the Life Science sector, so his departure (despite being good news) may have hampered progress. But their 25 Feb 20 Trading Statement said: "Life Science has made significant progress throughout the period and revenue for Prolong increased by 71% on the previous year as a result of DTC sales driven by online 'influencers', predominantly in the US. This growth comes from a low base, however we are pleased with the progress made through our digital channels. We believe this approach will give us a solid platform to market the product through other channels. As previously announced, we have signed two major distribution agreements in Hong Kong and for the Gulf countries. The revenue from these agreements will be recognised once regulatory approvals are completed and our distributors are able to sell the products into aforementioned countries. Obtaining regulatory approvals is a long and arduous process but with our new manufacturer in Korea we are only awaiting ISO certification which should be completed within the next month. The existing and forthcoming regulatory approvals will enable us to sell in the US, Australia, Hong Kong, China, Canada and the Gulf countries. We are currently in the process of working towards our CE mark with our agent which will open up the UK and European markets. We are in discussions with an Indian distributor and currently researching the South American market."
lord loads of lolly
15/6/2020
11:48
At the moment they're not really doing anything with Prolong. There are some registrations due, which might push things along, however they might have been delayed due to COVID-19.Even if they do get approved it's not something we currently have the team for to drive it forward.It's a completely different sell to the topical side and we've got plenty to concentrate on that side as well.Regarding the £4 I agree it won't be for some time. I'm looking at a 2 to 3 year timescale and only if things go to plan like I hope they will.
boonboon
15/6/2020
11:09
Just clarifying, as for some reason, ADVFN auto-edited my previous comment about Prolong to read "high share price" rather than "high selling price".
lord loads of lolly
Chat Pages: Latest  941  940  939  938  937  936  935  934  933  932  931  930  Older
ADVFN Advertorial
Your Recent History
LSE
IDP
Innovaderm..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210413 23:40:27